Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesImmunology/RheumatologyHighmark Blueshield Neny Prior Auth Form Coverage …
    Ask Trek AI about this page
    CurrentHighmark Blueshield NenyPolicy N/A

    Medication Prior Authorization Form - Coverage Criteria

    Customize your policy alerts

    Sign up for all Highmark Blueshield Neny policy alerts

    Know when Highmark Blueshield Neny releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Form and instructions to request prior authorization for prescription medications for Highmark members; used by prescribing providers to submit clinical and administrative information required for authorization decisions.

    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyMedication Prior Authorization Form - Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit a separate completed prior authorization form for each medication and fax to 1-866-240-8123 or mail to the address provided.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1-866-240-8123fax number for submission
    1form to be submitted per medication
    Includes checklisttherapies listed for failure documentation

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria

    Authorization criteria

    Coverage is considered when required documentation and criteria are provided.

    Submission completeness: Form is fully completed for the requested medication with member and provider information, drug name/strength/quantity/day supply, directions, diagnosis/ICD-10 codes, and signature

    Submit a separate form per medication; fax to 1-866-240-8123 or mail to 120 Fifth Avenue, SPECARE, Pittsburgh, PA 15222; print/type or write legibly in blue or black ink

    Clinical justification: Provide clinical information including whether induction dosing is required; if currently on therapy, provide documentation of disease stability or improvement; document prior therapeutic failures by selecting applicable agents from the checklist or listing others

    Include member weight with unit (lb or kg) for dosing calculations

    Authorization does not guarantee payment and payment is subject to member eligibility. Providers must submit a separate completed prior authorization form for each medication; forms and all clinical documentation should be faxed to 1-866-240-8123 or mailed to 120 Fifth Avenue, SPECARE, Pittsburgh, PA 15222. Incomplete submissions or missing clinical information may result in denial or delayed processing.

    Coding & Supply

    Requested Day Supply
    Options30 days; 90 days; other (blank option on form)
    Member weight
    Required informationProvide member weight and include unit of measure (for example, lb or kg)
    Induction dosing
    Induction dosing questionForm asks: 'Does the member require induction dosing?' with options Yes or No
    If YesProvider must indicate specifics of induction dosing on the form (space provided for details)
    Related documentation

    Provider Submission & Documentation Requirements

    Denial Risk

    Incomplete submission risk

    Incomplete or missing information on the prior authorization form or absent supporting clinical documentation may result in denial or processing delays. Payment remains subject to member eligibility and benefits; authorization does not guarantee payment.

    • Ensure all fields on the form are complete and legible.
    • Attach all required clinical records (see documentation callout).
    • Allow adequate time for review — incomplete submissions will be returned or denied.
    Documentation Required

    Administrative documentation required

    Provide complete administrative/provider information with the submission. The prescribing physician (PCP or Specialist) should, in most cases, complete the form.

    • Physician name, NPI, address (required for physician notification), phone and fax.

    Background

    This form is used to request prior authorization for specialty and disease-modifying medications typically prescribed by specialists (for example, rheumatologists, dermatologists, ophthalmologists, and immunologists). It collects clinical details needed for authorization decisions, including prior therapy history (step-therapy items), whether induction dosing is required, current therapy status and response, diagnosis/ICD-10 code(s), and member weight for dose calculations. The prescribing physician should, in most cases, complete the form and provide their full address for notification.

    Revision History

    instructions_updatedLatest

    Form instructions specify submission methods (fax to 1-866-240-8123 or mail to 120 Fifth Avenue, SPECARE, Pittsburgh, PA 15222) and that a separate form is required for each medication, with legible completion in blue or black ink.

    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyMedication Prior Authorization Form - Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit a separate completed prior authorization form for each medication and fax to 1-866-240-8123 or mail to the address provided.
    SourceLink
    On This Page
    Coverage CriteriaCoding & SupplyProvider Submission & Documentation RequirementsBackgroundRevision History
    Attach clinical documentation of induction dosing if applicable as part of required supporting materials
  1. Physician signature and date.
  2. Member identifying information (name, date of birth, member ID) and prescriber contact details.
  3. Submit a separate completed prior authorization form for each medication.
  4. Step Therapy

    Prior therapy / step therapy documentation

    Document prior therapy and step-therapy history demonstrating therapeutic failure, intolerance, or contraindication to applicable conventional therapies as required.

    • List all prior therapies tried and the reason for failure (e.g., lack of efficacy, adverse reaction, intolerance).
    • Common therapies to document include methotrexate, leflunomide, sulfasalazine, cyclosporine, hydroxychloroquine, phototherapy (PUVA/UVB), azathioprine, NSAIDs, local glucocorticoid injection, mercaptopurine, systemic corticosteroids (e.g., prednisone), and others as clinically relevant.
    • Include dates/duration of prior therapies and any supporting clinical notes or lab results.